Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
A lot of the microstructure debate centers around “Reg NMS.” But what is Reg NMS? And what are those rule numbers people quote? Well, Reg stands for Regulation and NMS stands for National Market ...
WE REPORT A CASE INVOLVING AN 81-YEAR-OLD man with schizoaffective disorder who presented with neuroleptic malignant syndrome (NMS) after an increase in his neuroleptic dose. NMS, a rare but ...
LOS ANGELES, CA / ACCESS Newswire / May 12, 2025 / NMS Capital Group ("NMS") is proud to announce its inclusion in the Los Angeles Business Journal's 2024 list of Top Private Equity Firms, published ...
Neuroleptic malignant syndrome (NMS) is a reaction to some specific types of medications. It’s characterized by symptoms like very high fever, rigid muscles, and rapid heartbeat. Although rare, NMS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback